A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M, Pitea A, Mittelbronn M, Steinbach J, Sticht C, Zehentmayr F, Piehlmaier D, Zitzelsberger H, Ganswindt U, Rödel C, Lauber K, Belka C, Unger K.
Niyazi M, et al. Among authors: zehentmayr f.
Oncotarget. 2016 Jul 19;7(29):45764-45775. doi: 10.18632/oncotarget.9945.
Oncotarget. 2016.
PMID: 27302927
Free PMC article.